Profund Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Profund Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,510	Closed	-$615K	–	1219
2020 Q3	$615K	Sell	4,510 -219	-5%	-$23.3K	0.03%	390
2020 Q2	$457K	Buy	+4,729	New	+$394K	0.03%	420
2020 Q1	–	Sell	-4,579	Closed	-$334K	–	1237
2019 Q4	$334K	Buy	+4,579	New	+$278K	0.01%	847
2019 Q1	–	Sell	-5,117	Closed	-$250K	–	1256
2018 Q4	$250K	Sell	5,117 -1,900	-27%	-$105K	0.02%	894
2018 Q3	$458K	Buy	+7,017	New	+$413K	0.02%	892

Profund Advisors's MYOK Position: Q4 2020 in Review

Profund Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 4,510 shares — an estimated $615K sold.

Profund Advisors first reported a position in MYOK in Q3 2018 and held it in 5 quarters. The position peaked at $615K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Profund Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Profund Advisors sold 4,510 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $615K.
Profund Advisors first reported a position in MyoKardia, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
Profund Advisors's MyoKardia, Inc. Common Stock position peaked at $615K in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Profund Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.